Search
Fibrobiologics Inc
FBLGAdd to Watchlist
0.875USD
-0.031-3.40%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
3.08MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.40%
5 Days
+5.98%
1 Month
-18.18%
6 Months
-81.75%
Year to Date
-80.54%
1 Year
-92.85%
Key Figures
0.907Open
0.930High
59.07KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.68%Turnover Ratio
0.906Prev. Close
0.875Low
30.71KTurnover
LossP/E Static
1.18P/B
0.00%Div Yield TTM
-215.16%ROA
19.80052wk High
0.28Volume Ratio
-11.16MNet Profit
3.51MShares
-6.9672EPS TTM
--Beta
-754.75%ROE
0.95252wk Low
6.01%Amplitude
--Gross Margin
3.08MMarket Cap
-2.10Reward/Risk
7.29%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Fibrobiologics Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Fibrobiologics Inc Info
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.
Ticker SymbolFBLG
CompanyFibrobiologics Inc
CEOO'Heeron (Pete)
Websitehttps://fibrobiologics.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Fibrobiologics Inc (FBLG)?
The current price of Fibrobiologics Inc (FBLG) is 0.88.
What is the symbol of Fibrobiologics Inc?
The ticker symbol of Fibrobiologics Inc is FBLG.
What is the 52-week high of Fibrobiologics Inc?
The 52-week high of Fibrobiologics Inc is 19.80.
What is the 52-week low of Fibrobiologics Inc?
The 52-week low of Fibrobiologics Inc is 0.95.
What is the market capitalization of Fibrobiologics Inc?
The market capitalization of Fibrobiologics Inc is 3.08M.
Is Fibrobiologics Inc (FBLG) currently rated as Buy, Hold, or Sell?
According to analysts, Fibrobiologics Inc (FBLG) has an overall rating of Buy, with a price target of 13.50.
What is the Earnings Per Share (EPS TTM) of Fibrobiologics Inc (FBLG)?
The Earnings Per Share (EPS TTM) of Fibrobiologics Inc (FBLG) is -8.35.